© 2023 MJH Life Sciences and Cancer Network. All rights reserved.
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Shaji Kumar, MD reviews updates from ASH 2022 with a panel of experts, focusing on the use of bispecifics in the treatment of patients with multiple myeloma.
December 14th 2022